scholarly journals Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors—a requisite for correct data evaluation

2018 ◽  
Vol 410 (21) ◽  
pp. 5101-5105 ◽  
Author(s):  
Annekathrin Haberland ◽  
Johannes Müller ◽  
Gerd Wallukat ◽  
Katrin Wenzel
Biochemistry ◽  
2001 ◽  
Vol 40 (26) ◽  
pp. 7761-7772 ◽  
Author(s):  
David C. Teller ◽  
Tetsuji Okada ◽  
Craig A. Behnke ◽  
Krzysztof Palczewski ◽  
Ronald E. Stenkamp

2019 ◽  
Vol 35 (14) ◽  
pp. i324-i332 ◽  
Author(s):  
Jiansheng Wu ◽  
Ben Liu ◽  
Wallace K B Chan ◽  
Weijian Wu ◽  
Tao Pang ◽  
...  

Abstract Motivation Accurate prediction and interpretation of ligand bioactivities are essential for virtual screening and drug discovery. Unfortunately, many important drug targets lack experimental data about the ligand bioactivities; this is particularly true for G protein-coupled receptors (GPCRs), which account for the targets of about a third of drugs currently on the market. Computational approaches with the potential of precise assessment of ligand bioactivities and determination of key substructural features which determine ligand bioactivities are needed to address this issue. Results A new method, SED, was proposed to predict ligand bioactivities and to recognize key substructures associated with GPCRs through the coupling of screening for Lasso of long extended-connectivity fingerprints (ECFPs) with deep neural network training. The SED pipeline contains three successive steps: (i) representation of long ECFPs for ligand molecules, (ii) feature selection by screening for Lasso of ECFPs and (iii) bioactivity prediction through a deep neural network regression model. The method was examined on a set of 16 representative GPCRs that cover most subfamilies of human GPCRs, where each has 300–5000 ligand associations. The results show that SED achieves excellent performance in modelling ligand bioactivities, especially for those in the GPCR datasets without sufficient ligand associations, where SED improved the baseline predictors by 12% in correlation coefficient (r2) and 19% in root mean square error. Detail data analyses suggest that the major advantage of SED lies on its ability to detect substructures from long ECFPs which significantly improves the predictive performance. Availability and implementation The source code and datasets of SED are freely available at https://zhanglab.ccmb.med.umich.edu/SED/. Supplementary information Supplementary data are available at Bioinformatics online.


IUCrJ ◽  
2019 ◽  
Vol 6 (6) ◽  
pp. 1106-1119 ◽  
Author(s):  
Andrii Ishchenko ◽  
Benjamin Stauch ◽  
Gye Won Han ◽  
Alexander Batyuk ◽  
Anna Shiriaeva ◽  
...  

Rational structure-based drug design (SBDD) relies on the availability of a large number of co-crystal structures to map the ligand-binding pocket of the target protein and use this information for lead-compound optimization via an iterative process. While SBDD has proven successful for many drug-discovery projects, its application to G protein-coupled receptors (GPCRs) has been limited owing to extreme difficulties with their crystallization. Here, a method is presented for the rapid determination of multiple co-crystal structures for a target GPCR in complex with various ligands, taking advantage of the serial femtosecond crystallography approach, which obviates the need for large crystals and requires only submilligram quantities of purified protein. The method was applied to the human β2-adrenergic receptor, resulting in eight room-temperature co-crystal structures with six different ligands, including previously unreported structures with carvedilol and propranolol. The generality of the proposed method was tested with three other receptors. This approach has the potential to enable SBDD for GPCRs and other difficult-to-crystallize membrane proteins.


2018 ◽  
pp. 301-329 ◽  
Author(s):  
Benjamin Stauch ◽  
Linda Johansson ◽  
Andrii Ishchenko ◽  
Gye Won Han ◽  
Alexander Batyuk ◽  
...  

2021 ◽  
Author(s):  
Kaihua Zhang ◽  
Hao Wu ◽  
Nicholas Hoppe ◽  
Aashish Manglik ◽  
Yifan Cheng

Single particle cryogenic-electron microscopy (cryo-EM) is used extensively to determine structures of activated G protein-coupled receptors (GPCRs) in complex with G proteins or arrestins. However, applying it to GPCRs without signaling proteins remains challenging because most receptors lack structural features in their soluble domains to facilitate image alignment. In GPCR crystallography, inserting a fusion protein between transmembrane helices 5 and 6 is a highly successful strategy for crystallization. Although the similar strategy has the potential to broadly facilitate cryo-EM structure determination of GPCRs alone without signaling protein, the critical determinants that make this approach successful are not yet clear. Here, we address this shortcoming by exploring different fusion protein designs, which led to structures of antagonist bound A2A adenosine receptor at 3.4&Aring resolution and unliganded Smoothened at 3.7&Aring resolution. The fusion strategies explored here are likely applicable to cryo-EM interrogation of other GPCRs and small integral membrane proteins.


Sign in / Sign up

Export Citation Format

Share Document